000195452 000__ 01487fam\a2200337\a\4500
000195452 001__ 195452
000195452 005__ 20220217103819.0
000195452 008__ 970912s1997\\\\dcua\\\\\b\\\f000\0\eng\d
000195452 020__ $$a0160552133
000195452 035__ $$a(OCoLC)ocm37611162
000195452 035__ $$9(IS)TVZ6402
000195452 035__ $$9AAW5150SI
000195452 035__ $$a195452
000195452 040__ $$aGPO$$cGPO
000195452 043__ $$an-us---
000195452 049__ $$aISUW
000195452 074__ $$a1019-A-01
000195452 0860_ $$aY 4.C 73/8:105-21
000195452 088__ $$aSerial no. 105-21 (United States. Congress. House. Committee on   Commerce)
000195452 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Commerce.$$bSubcommittee on Health and the Environment.
000195452 24510 $$aReauthorization of the Prescription User Fee Act and FDA reform :$$bhearing before the Subcommittee on Health and Environment of the Committee   on Commerce, House of Representatives, One Hundred Fifth Congress, first        session, April 23, 1997.
000195452 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1997.
000195452 300__ $$aiii, 136 p. :$$bill. ;$$c24 cm.
000195452 500__ $$aDistributed to some depository libraries in microfiche.
000195452 500__ $$aShipping list no.: 97-0347-P.
000195452 500__ $$a"Serial no. 105-21."
000195452 504__ $$aIncludes bibliographical references.
000195452 61010 $$aUnited States.$$bFood and Drug Administration$$xManagement.
000195452 650_0 $$aDrugs$$xPrices$$xLaw and legislation$$zUnited States.
000195452 650_0 $$aPrescription pricing$$xLaw and legislation$$zUnited States.
000195452 85230 $$bdfich$$hY 4.C 73/8:$$i105-21
000195452 909CO $$ooai:library.usi.edu:195452$$pGLOBAL_SET
000195452 948__ $$ac:jb
000195452 980__ $$aBIB
000195452 980__ $$aGOV RESOURCE